Home › Kanser sa Suso › California › Baldwin Park
Pag-aaral pangklinika para sa Kanser sa Suso sa Baldwin Park, CA
44 pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Baldwin Park (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Nagre-recruitPhase 3
- City of Hope National Medical Center, Duarte · 4 mi ang layo
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Nagre-recruitPhase 2
- City of Hope - Duarte Cancer Center, Duarte · 4 mi ang layo
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Nagre-recruitPhase 3
- City of Hope National Medical, Duarte · 4 mi ang layo
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 2
- City of Hope, Duarte · 4 mi ang layo
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
Nagre-recruitPhase 2
- City of Hope Medical Center, Duarte · 4 mi ang layo
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Nagre-recruitPhase 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Nagre-recruitPhase 1
- Research Site, Duarte · 4 mi ang layo
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Nagre-recruitPhase 2
- City of Hope, Duarte · 4 mi ang layo
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Nagre-recruitPhase 3
- City of Hope, Duarte · 4 mi ang layo
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Nagre-recruitPhase 2
- City of Hope, Duarte · 4 mi ang layo
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Nagre-recruitPhase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Nagre-recruitPhase 1/2
- City of Hope, Duarte · 4 mi ang layo
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Nagre-recruitPhase 3
- City of Hope National Medical Center, Duarte · 4 mi ang layo
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Nagre-recruitPhase 1/2
- City of Hope - Duarte, Duarte · 4 mi ang layo
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Nagre-recruitPhase 3
- Research Site, Duarte · 4 mi ang layo
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Nagre-recruitPhase 1/2
- City of Hope, Duarte · 4 mi ang layo
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Nagre-recruitPhase 1/2
- City of Hope, Duarte · 4 mi ang layo
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Nagre-recruitPhase 3
- Kaiser Permanente-Baldwin Park, Baldwin Park
Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- City of Hope Medical Center, Duarte · 4 mi ang layo
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Nagre-recruitPhase 2
- City of Hope--Duarte, Duarte · 4 mi ang layo
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Nagre-recruit
- City of Hope Medical Center, Duarte · 4 mi ang layo
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Nagre-recruitPhase 3
- City of Hope - Duarte Cancer Center, Duarte · 4 mi ang layo
E-Mindfulness Approaches for Living After Breast Cancer
Nagre-recruitPhase 3
- Kaiser Permanente-Baldwin Park, Baldwin Park
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4 mi ang layo
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Nagre-recruitPhase 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
Nagre-recruitPhase 4
- City of Hope Medical Center, Duarte · 4 mi ang layo
Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- City of Hope Medical Center, Duarte · 4 mi ang layo
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
Nagre-recruitPhase 2
- City of Hope Medical Center, Duarte · 4 mi ang layo
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Nagre-recruitPhase 3
- City of Hope Medical Center, Duarte · 4 mi ang layo
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Nagre-recruitPhase 2
- City of Hope, Duarte · 4 mi ang layo
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Nagre-recruit
- Beckman Research Institute of City of Hope, Duarte · 4 mi ang layo
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- City of Hope, Duarte · 4 mi ang layo
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- City of Hope Medical Center, Duarte · 4 mi ang layo
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
Nagre-recruitPhase 2
- City of Hope Medical Center, Duarte · 4 mi ang layo
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
Nagre-recruitPhase 2
- City of Hope Medical Center, Duarte · 4 mi ang layo
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
Nagre-recruitPhase 2
- City of Hope Medical Center, Duarte · 4 mi ang layo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Duarte · 4 mi ang layo
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Nagre-recruitPhase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
Nagre-recruitPhase 2
- City of Hope Medical Center, Duarte · 4 mi ang layo
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
Nagre-recruitPhase 1
- City of Hope Medical Center, Duarte · 4 mi ang layo
Pag-aaral para sa Kanser sa Suso sa ibang lungsod
- New York City, NY136 pag-aaral
- Houston, TX126 pag-aaral
- Boston, MA112 pag-aaral
- Nashville, TN81 pag-aaral
- Los Angeles, CA73 pag-aaral
- Edison, NJ68 pag-aaral
- St. Louis, MO64 pag-aaral
- Queens, NY64 pag-aaral
- Durham, NC64 pag-aaral
- Chicago, IL59 pag-aaral
- Philadelphia, PA56 pag-aaral
- Dallas, TX55 pag-aaral
Iba pang pag-aaral sa Baldwin Park
- Acute Myeloid Leukemia40 pag-aaral
- Colorectal Cancer37 pag-aaral
- Non-Small Cell Lung Cancer36 pag-aaral
- Kanser (lahat ng uri)34 pag-aaral
- Kanser sa Prostate30 pag-aaral
- Metastatic Cancer30 pag-aaral
- Myelodysplastic Syndromes26 pag-aaral
- Kanser sa Ovary25 pag-aaral
- Kanser sa Baga24 pag-aaral
- Multiple Myeloma23 pag-aaral
- Kanser sa Tiyan22 pag-aaral
- Acute Lymphoblastic Leukemia21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.